Latest News

Quadrivalent modRNA Influenza Vaccine Shows Superior Efficacy to Licensed Inactivated Vaccine in Phase 3 Trial / Image credit:©tan/AdobeStock
Quadrivalent modRNA Influenza Vaccine Shows Superior Efficacy to Licensed Inactivated Vaccine in Phase 3 Trial

November 20th 2025

Results showed that Pfizer’s mRNA vaccine cut influenza-like illness by 34.5% compared with a standard influenza vaccine.

Most Parents Support Childhood Vaccines, But Doubt Flu and COVID-19 Shots: Daily Dose / Image credit: ©New Africa/AdobeStock
Most Parents Support Childhood Vaccines, But Doubt Flu and COVID-19 Shots: Daily Dose

October 20th 2025

Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials / Image credit:  ©artegorov3@gmail/AdobeStock
Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials

October 15th 2025

WHO: 1 in 6 Common Infections Now Drug-Resistant as AMR Threatens Global Health / image credit ©royaltystockphoto/shutterstock.com
WHO: 1 in 6 Common Infections Now Drug-Resistant, AMR Threatens Global Health

October 13th 2025

Measles Outbreak Fails to Push MMR Rates to Herd Immunity Levels /  image credit ©Tryfonov/stock.adobe.com
Measles Outbreak Fails to Push MMR Rates to Herd Immunity Levels, Study Reveals

September 30th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.